Idiopathic Pulmonary Fibrosis (IPF) Summit is organized by Hanson Wade and would be held during Aug 21 - 23, 2017 at Sheraton Boston Hotel, Boston, Massachusetts, United States Of America.
This unique meeting is your opportunity to join the leading minds across biopharma and academia to reduce the expansive translational gap that exists in current IPF drug development.
Across 3 jam-packed days the brightest minds from the likes of Boehringer Ingelheim, Promedior, Fibrogen and many more will be sharing their insight and lessons learned to collectively enable the community to:
• Effectively translate into the clinic by better recapitulating IPF through robust in vitro and vivo models
• Define more meaningful preclinical endpoints to aid identification of novel targets and development of more
effective IPF therapeutics
• Validate non-invasive biomarker and diagnostic techniques for back translation and ultimately achieve greater
clinical benefit
Prices:
• Conference + 2 Workshops: USD 3897
• Conference + 1 Workshop: USD 3298
• Conference Only: USD 2699
Speakers: Clifford D. Wright, Glenn Rosen, Masha Poyurovsky, Seth Porter, Joan Nichols, Lynne Murray, A. Bruce Montgomery, Phillip Monk, Fernando Martinez, Kenneth Lipson, Joseph Jacob, Rick Jack, Cory M. Hogaboam, Gerald Horan, Joe Arron, James A. Cardelli, Sam Cobb, Gregory Cosgrove, Jeremy Duffield, Jonathan Goldin